FDA-owned Flatiron Health is expanding its partnership with the US Food and Drug Administration (Roche), which seeks to overhaul what data is used in clinical trials. Flatiron uses data from electronic health records instead of traditional clinical trial data. The research relationship between the two organisations will mean the Roche can further examine how to use Flatiron's real-world treatment data in order to make clinical decisions.
Roche-owned Flatiron Health is expanding its partnership with the US Food and Drug Administration (FDA), which seeks to overhaul what data is used in clinical trials. Flatiron uses data from electronic health records instead of traditional clinical trial data. The research relationship between the two organisations will mean the FDA can further examine how to use Flatiron's real-world treatment data in order to make clinical decisions.